Does High Plasma Immunoglobulin E in COPD Predict Exacerbation, Mortality Risk?
Could the level of plasma immunoglobulin E in patients with COPD serve as a potential biomarker for predicting future exacerbation risk and mortality?
Chronic Obstructive Pulmonary Disease
Ensifentrine Improves Lung Function, Reduces COPD Exacerbations in Late Stage Trial
Ensifentrine (RPL554) is a first-in-class, dual phosphodiesterase (PDE) 3 and 4 inhibitor with combined bronchodilator and anti-inflammatory actions.
COPD and Moderate Hypoxemia: Is Home Oxygen Beneficial?
Does home oxygen — either nocturnal oxygen therapy or LTOT — make a difference in the 3-year survival of patients with COPD and moderate hypoxemia?
Symptomatic Undiagnosed COPD and Asthma: Disease Burden and Quality of Life
How do individuals with undiagnosed asthma and COPD manifest these conditions over time, and how do these undiagnosed conditions affect quality of life?
Frequent Productive Cough Common in Patients With Chronic Obstructive Lung Disease, Asthma
Researchers assessed the occurrence and associated outcomes of frequent productive cough among patients with chronic obstructive lung disease and asthma.
COPD Triple Therapy: Single- vs Multiple-Inhaler Outcomes
In COPD, how does using single-inhaler triple therapy instead of multiple-inhaler triple therapy affect health care costs, mortality, and treatment adherence?
Pulmonary Rehabilitation: Cost-Effectiveness for US Patients With COPD
How does pulmonary rehabilitation of patients after COPD-related hospitalizations affect the overall cost of care and quality-adjusted life expectancy?
Can Probiotics Improve Muscle Strength in Older Patients With COPD?
Can preventing gut permeability via multistrain probiotics prevent the muscle weakness and atrophy that often develops in older patients with COPD?
Asthma and COPD: Effect of Ongoing Relationship With Health Care Provider
Does having an ongoing relationship with a health care provider — ie, relational continuity — affect outcomes in patients with asthma and COPD?
COPD Exacerbations: LABA/LAMA Dual Bronchodilation vs LABA/ICS Combination
Which therapy more effectively prevents COPD exacerbations: dual bronchodilation with a long-acting beta agonist and a long-acting antimuscarinic agent, or LABA/ICS?
- Loading...
Loading...
Next post in COPD
Loading... 
Loading...